Ds Med Llc - May 17, 2022 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
10%+ Owner
Signature
/s/ Paul T. Lehr, attorney-in-fact
Stock symbol
LGVN
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/19/2022, 06:00 PM
Previous filing
Apr 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Common Stock Other $0 -7.02M -100% $0.00* 0 May 17, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ds Med Llc is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2 Shares distributed on a pro rated basis to members of DS Med, LLC, for no consideration.